Sign In
Buy HROW
Imprimis Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 20.10. In total, the insiders bought 11.77M and sold 2.32M HROW shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
20.10 |
| ● Buy | 11.77M shares |
| ● Sell | 2.32M shares |
|
60% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 12, 2025 Sell |
Opaleye Management Inc. 10 Percent Owner |
10 000 Value: $259.0K |
||
|
May 12, 2025 Sell |
Opaleye Management Inc. 10 Percent Owner |
10 000 Value: $259.0K |
||
|
Apr 07, 2025 Sell |
Boll Andrew R. Chief Financial Officer |
136 745 Value: $3.16M |
||
|
Apr 07, 2025 Sell |
Saharek John P. CEO & President, Imprimisrx |
109 475 Value: $2.53M |
||
|
Apr 07, 2025 Sell |
Baum Mark L Chief Executive Officer |
300 363 Value: $6.94M |
||
|
Apr 07, 2025 Sell |
Baum Mark L Chief Executive Officer |
300 363 Value: $6.94M |
||
|
Apr 07, 2025 Sell |
Saharek John P. CEO & President, Imprimisrx |
109 475 Value: $2.53M |
||
|
Apr 07, 2025 Sell |
Boll Andrew R. Chief Financial Officer |
136 745 Value: $3.16M |
||
|
Apr 03, 2025 Buy |
Boll Andrew R. Chief Financial Officer |
346 500 Value: $8.34M |
||
|
Apr 03, 2025 Buy |
Boll Andrew R. Chief Financial Officer |
346 500 Value: $8.34M |
||
|
Apr 03, 2025 Buy |
Saharek John P. CEO & President, Imprimisrx |
277 200 Value: $6.67M |
||
|
Apr 03, 2025 Buy |
Saharek John P. CEO & President, Imprimisrx |
277 200 Value: $6.67M |
||
|
Apr 03, 2025 Buy |
Baum Mark L Chief Executive Officer |
762 300 Value: $18.3M |
||
|
Apr 03, 2025 Buy |
Baum Mark L Chief Executive Officer |
762 300 Value: $18.3M |
||
|
Apr 03, 2025 Buy |
Baum Mark L Chief Executive Officer |
762 300 Value: $18.3M |
||
|
Apr 03, 2025 Buy |
Baum Mark L Chief Executive Officer |
762 300 Value: $18.3M |
||
|
Apr 03, 2025 Buy |
Saharek John P. CEO & President, Imprimisrx |
277 200 Value: $6.67M |
||
|
Apr 03, 2025 Buy |
Saharek John P. CEO & President, Imprimisrx |
277 200 Value: $6.67M |
||
|
Apr 03, 2025 Buy |
Boll Andrew R. Chief Financial Officer |
346 500 Value: $8.34M |
||
|
Apr 03, 2025 Buy |
Boll Andrew R. Chief Financial Officer |
346 500 Value: $8.34M |
||
|
Mar 24, 2025 Sell |
Opaleye Management Inc. 10 Percent Owner |
5 000 Value: $150.1K |
||
|
Mar 24, 2025 Sell |
Opaleye Management Inc. 10 Percent Owner |
5 000 Value: $150.1K |
||
|
Mar 18, 2025 Sell |
Opaleye Management Inc. 10 Percent Owner |
5 000 Value: $150.1K |
||
|
Mar 18, 2025 Sell |
Opaleye Management Inc. 10 Percent Owner |
5 000 Value: $150.1K |
||
|
Mar 18, 2025 Sell |
Opaleye Management Inc. 10 Percent Owner |
5 000 Value: $148.2K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
